Both people and products – as ‘citizens’ and ‘science’ – appear in Mark Flear’s chapter on EU biomedical research law and policy. Flear shows how the spaces created for biomedical research by EU law and policy embody a particular type of citizen, and play on narratives of hope and promise. The result is an obfuscation of the dominant drivers of market-oriented norms and values, and a legitimation of particular types of EU health law and policy.
Other access options
Log in with Open Athens, Shibboleth, or your institutional credentials
Log in with your Elgar Online account